Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Orthofix International NV Issues Q4 2012 Guidance; Revenue Guidance Below Analysts' Estimates; Lowers FY 2012 Guidance


Monday, 7 Jan 2013 04:00pm EST 

Orthofix International NV announced that for the fourth quarter of 2012, it expects net sales to be approximately $112 million and adjusted earnings from continuing operations per share (EPS) to be between $0.78 and $0.83. For fiscal 2012, it expects net sales from continuing operations to be approximately $462 million and adjusted earnings from continuing operations per share (EPS) to be between $3.01 and $3.06. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $123 million and EPS of $0.82 for the fourth quarter of 2012; revenues of $473 million and EPS of $3.05 for fiscal 2012. 

Company Quote

30.78
-0.03 -0.10%
26 Dec 2014